Compare Mandiri Herindo Adiperkasa Tbk. (MAHA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mandiri Herindo Adiperkasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp145 (market cap 2.42T, 4.28M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 14.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (4.28M versus 324K). Which is the better fit depends on your goals.
| MAHA | OBAT | |
|---|---|---|
Market Cap | 2.42T | 166.01B |
Volume | 4.28M | 324K |
Lot | 42.79K | 3.24K |
Turnover | 613.55M | 77.68M |
Average Price | 143.4 | 239.75 |
Value | 613.55M | 77.68M |
Indicative Equilibrium Price | 145 | 240 |
Indicative Equilibrium Volume | 48 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mandiri Herindo Adiperkasa Tbk.
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
